Viemed Healthcare (NASDAQ:VMD) Releases Quarterly Earnings Results

Viemed Healthcare (NASDAQ:VMDGet Free Report) issued its quarterly earnings results on Monday. The company reported $0.10 EPS for the quarter, topping analysts’ consensus estimates of $0.08 by $0.02, Zacks reports. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%. Viemed Healthcare updated its FY 2025 guidance to EPS.

Viemed Healthcare Trading Down 1.3 %

Shares of VMD traded down $0.10 during trading hours on Monday, hitting $7.40. The stock had a trading volume of 105,696 shares, compared to its average volume of 143,943. The company’s fifty day simple moving average is $8.01 and its 200 day simple moving average is $8.19. Viemed Healthcare has a 12-month low of $6.21 and a 12-month high of $10.00. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.19 and a current ratio of 1.31. The firm has a market cap of $288.13 million, a P/E ratio of 27.41 and a beta of 1.50.

About Viemed Healthcare

(Get Free Report)

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.

Featured Stories

Earnings History for Viemed Healthcare (NASDAQ:VMD)

Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.